MyFinsight
Home
Blog
About
Marketable securities
$2,593,626K
(-20.56%↓ Y/Y)
Cash and cash
equivalents
$1,248,456K
(0.81%↑ Y/Y)
Litigation settlement
receivable
$771,627K
Other current assets
$128,371K
(14.01%↑ Y/Y)
Total current assets
$4,742,080K
(2.74%↑ Y/Y)
Investments measured at fair
value
$444,622K
(56.66%↑ Y/Y)
Operating lease
right-of-use assets
$78,886K
(-9.41%↓ Y/Y)
Other assets
$29,585K
(-4.85%↓ Y/Y)
Property and equipment,
net
$11,320K
(-23.85%↓ Y/Y)
Total assets
$5,306,493K
(5.44%↑ Y/Y)
Total liabilities and
shareholders equity
$5,306,493K
(5.44%↑ Y/Y)
Total shareholders
equity
$4,921,869K
(2.20%↑ Y/Y)
Total liabilities
$384,624K
(77.49%↑ Y/Y)
Shareholders equity
attributable to roivant...
$4,231,273K
(-2.63%↓ Y/Y)
Noncontrolling interests
$690,596K
(46.85%↑ Y/Y)
Total current
liabilities
$283,603K
(149.07%↑ Y/Y)
Operating lease
liabilities, noncurrent
$94,768K
(4.96%↑ Y/Y)
Other liabilities
$6,253K
(2642.54%↑ Y/Y)
Accumulated deficit
-$900,354K
(-185.29%↓ Y/Y)
Additional paid-in capital
$5,130,926K
(10.48%↑ Y/Y)
Accrued expenses
$168,740K
(90.18%↑ Y/Y)
Income tax payable
$74,182K
Accounts payable
$25,084K
(117.18%↑ Y/Y)
Operating lease
liabilities
$12,384K
(31.72%↑ Y/Y)
Other current
liabilities
$3,213K
(-23.24%↓ Y/Y)
Accumulated other
comprehensive income
$701K
(-95.91%↓ Y/Y)
Back
Back
Balance Sheet
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
source: myfinsight.com